Research study Program year 2023 Source: CMS Open Payments

PaTHway TRIAL

ClinicalTrials.gov NCT04701203

Research payments

$694,652

107 payments

Through program year 2023, $694,652 in research payments was reported against PaTHway TRIAL, across 107 payments, paid by Ascendis Pharma, Inc..

Paid by: Ascendis Pharma, Inc.
ClinicalTrials.gov: NCT04701203

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$220,722	55
2022	Research	$473,930	52

Breakdown

Who paid Research payments · program years 2022–2023

Ascendis Pharma, Inc. $694,652 107 payments

Who received the money Research payments · program years 2022–2023

The Trustees Of Columbia University In The City Of New York Organisation paid for research $195,728 13 payments
Lisa G Abbott, MD A Professional Corporation Organisation paid for research $104,248 13 payments
KMW, Inc Organisation paid for research $98,745 16 payments
Northern California Institute Organisation paid for research $92,289 12 payments
The University of Chicago International House Organisation paid for research $89,477 10 payments
Mayo Clinic Organisation paid for research $48,726 15 payments
Arthritis Northwest Pllc Organisation paid for research $34,378 8 payments
Texas Diabetes & Endocrinology Organisation paid for research $24,103 17 payments
Thomas Jefferson University Organisation paid for research $4,500 1 payment
Indiana-Armstrong Endocrinology Associates Organisation paid for research $2,000 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.